<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">STAR-Echo: A Novel Biomarker for Prognosis of MACE in Chronic Kidney Disease Patients Using Spatiotemporal Analysis and Transformer-Based Radiomics Models</title>
				<funder ref="#_tCh3Kmp">
					<orgName type="full">Prostate Cancer Research Program</orgName>
				</funder>
				<funder ref="#_hKXzSwD">
					<orgName type="full">National Cancer Institute</orgName>
				</funder>
				<funder ref="#_rT779hS #_XUbQsXT #_teajDbJ #_xvVjBzX #_HFpDge5 #_VtNcrD4 #_nUXYsyt #_r4bEvE2 #_yR29XF5 #_hQ3N8V5 #_Mjuhm24">
					<orgName type="full">unknown</orgName>
				</funder>
				<funder>
					<orgName type="full">Bristol Myers-Squibb</orgName>
				</funder>
				<funder ref="#_7kUDfDz">
					<orgName type="full">National Heart, Lung and Blood Institute</orgName>
				</funder>
				<funder>
					<orgName type="full">U.S. Department of Veterans Affairs</orgName>
				</funder>
				<funder>
					<orgName type="full">Eli-Lilly</orgName>
				</funder>
				<funder ref="#_UvbxgdF #_TSAnsDR #_e2jDjH4">
					<orgName type="full">Peer Reviewed Cancer Research Program</orgName>
				</funder>
				<funder>
					<orgName type="full">Boehringer-Ingelheim</orgName>
				</funder>
				<funder>
					<orgName type="full">National Institutes of Health</orgName>
				</funder>
				<funder ref="#_abJJRyG #_m7yknFd">
					<orgName type="full">Lung Cancer Research Program</orgName>
				</funder>
				<funder ref="#_cGZtrNX">
					<orgName type="full">Kidney Precision Medicine Project</orgName>
					<orgName type="abbreviated">KPMP</orgName>
				</funder>
				<funder ref="#_s3cf8mb">
					<orgName type="full">United States Department of Veterans Affairs Biomedical Laboratory Research and Development Service the Office</orgName>
				</funder>
				<funder>
					<orgName type="full">Department of Defense</orgName>
				</funder>
				<funder ref="#_PvxXWBN #_MM5jttU">
					<orgName type="full">National Institute of Biomedical Imaging and Bioengineering</orgName>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Rohan</forename><surname>Dhamdhere</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Wallace H. Coulter Department of Biomedical Engineering</orgName>
								<orgName type="institution">Georgia Institute of Technology and Emory University</orgName>
								<address>
									<postCode>30322</postCode>
									<settlement>Atlanta</settlement>
									<region>GA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Gourav</forename><surname>Modanwal</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Wallace H. Coulter Department of Biomedical Engineering</orgName>
								<orgName type="institution">Georgia Institute of Technology and Emory University</orgName>
								<address>
									<postCode>30322</postCode>
									<settlement>Atlanta</settlement>
									<region>GA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Mohamed</forename><forename type="middle">H E</forename><surname>Makhlouf</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution">University Hospitals</orgName>
								<address>
									<settlement>Cleveland</settlement>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Neda</forename><forename type="middle">Shafiabadi</forename><surname>Hassani</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution">University Hospitals</orgName>
								<address>
									<settlement>Cleveland</settlement>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Satvika</forename><surname>Bharadwaj</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Wallace H. Coulter Department of Biomedical Engineering</orgName>
								<orgName type="institution">Georgia Institute of Technology and Emory University</orgName>
								<address>
									<postCode>30322</postCode>
									<settlement>Atlanta</settlement>
									<region>GA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Pingfu</forename><surname>Fu</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution">Case Western Reserve University</orgName>
								<address>
									<settlement>Cleveland</settlement>
									<region>OH</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ioannis</forename><surname>Milioglou</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution">University Hospitals</orgName>
								<address>
									<settlement>Cleveland</settlement>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Mahboob</forename><surname>Rahman</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution">University Hospitals</orgName>
								<address>
									<settlement>Cleveland</settlement>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">Case Western Reserve University</orgName>
								<address>
									<settlement>Cleveland</settlement>
									<region>OH</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sadeer</forename><surname>Al-Kindi</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution">University Hospitals</orgName>
								<address>
									<settlement>Cleveland</settlement>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">Case Western Reserve University</orgName>
								<address>
									<settlement>Cleveland</settlement>
									<region>OH</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Anant</forename><surname>Madabhushi</surname></persName>
							<email>anantm@emory.edu</email>
							<affiliation key="aff0">
								<orgName type="department">Wallace H. Coulter Department of Biomedical Engineering</orgName>
								<orgName type="institution">Georgia Institute of Technology and Emory University</orgName>
								<address>
									<postCode>30322</postCode>
									<settlement>Atlanta</settlement>
									<region>GA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="institution">Atlanta Veterans Affairs Medical Center</orgName>
								<address>
									<settlement>Atlanta</settlement>
									<region>GA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">STAR-Echo: A Novel Biomarker for Prognosis of MACE in Chronic Kidney Disease Patients Using Spatiotemporal Analysis and Transformer-Based Radiomics Models</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">D56BDBF8A878096399782EFD05DA1E34</idno>
					<idno type="DOI">10.1007/978-3-031-43987-228.</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.0" ident="GROBID" when="2024-03-24T11:03+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Chronic Kidney Disease (CKD) patients are at higher risk of Major Adverse Cardiovascular Events (MACE). Echocardiography evaluates left ventricle (LV) function and heart abnormalities. LV Wall (LVW) pathophysiology and systolic/diastolic dysfunction are linked to MACE outcomes (O -and O + ) in CKD patients. However, traditional LV volume-based measurements like ejection-fraction offer limited predictive value as they rely only on end-phase frames. We hypothesize that analyzing LVW morphology over time, through spatiotemporal analysis, can predict MACE risk in CKD patients. However, accurately delineating and analyzing LVW at every frame is challenging due to noise, poor resolution, and the need for manual intervention. Our contribution includes (a) developing an automated pipeline for identifying and standardizing heart-beat cycles and segmenting the LVW, (b) introducing a novel computational biomarker-STAR-Echo-which combines spatiotemporal risk from radiomic (MR) and deep learning (MT ) models to predict MACE prognosis in CKD patients, and (c) demonstrating the superior prognostic performance of STAR-Echo compared to MR, MT , as well as clinical-biomarkers (EF, BNP, and NT-proBNP) for characterizing cardiac dysfunction. STAR-Echo captured the gray level intensity distribution, perimeter and sphericity of the LVW that changes differently over time in individuals who encounter MACE outcomes.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Echo achieved an AUC of 0.71[0.53 -0.89] for MACE outcome classification and also demonstrated prognostic ability in Kaplan-Meier survival analysis on a holdout cohort (Sv = 44) of CKD patients (N = 150). It achieved superior MACE prognostication (p-value = 0.037 (log-rank test)), compared to MR (p-value = 0.042), MT (p-value = 0.069), clinical biomarkers-EF, BNP, and NT-proBNP (p-value &gt;0.05).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1">Introduction</head><p>Cardiovascular disease (CVD) is the most common cause of mortality among patients with Chronic Kidney disease (CKD), with CVD accounting for 40-50% deaths in patients with acute CKD <ref type="bibr" target="#b0">[1]</ref>. Echocardiography (Echo), a non-invasive imaging modality, provides a quick critical assessment of cardiac structure and function for cardiovascular disease diagnosis. Despite its usefulness, due to its nature, echo data is noisy and have poor resolution, which presents challenges in effectively interpreting and analyzing them. Measurements like Left ventricle (LV) volume captured by ejection fraction (EF), LV mass and LV geometry have been standard biomarkers for diagnosing and predicting severity of CVD <ref type="bibr" target="#b1">[2]</ref><ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref>. With the availability of large-scale public dataset like EchoNet <ref type="bibr" target="#b6">[7]</ref>, various works have even assimilated recent deep learning advances like graphs CNNs <ref type="bibr" target="#b7">[8]</ref> and transformers <ref type="bibr" target="#b8">[9]</ref> for EF estimation using automated LV segmentation from echo videos. However, recent studies on CKD patients demonstrated that standard echo measurements based on static LV volume and morphology, such as EF, may have limited prognostic value beyond baseline clinical characteristics, as adverse outcomes are to the common occurrence inspite of a preserved EF <ref type="bibr" target="#b10">[10]</ref><ref type="bibr" target="#b11">[11]</ref><ref type="bibr" target="#b12">[12]</ref>. As a result, studies have utilized machine learning to provide more detailed links to cardiac structure and function using echo data (measurements, images and videos) <ref type="bibr" target="#b10">[10]</ref><ref type="bibr" target="#b11">[11]</ref><ref type="bibr" target="#b12">[12]</ref><ref type="bibr" target="#b13">[13]</ref><ref type="bibr" target="#b14">[14]</ref>. LV Wall (LVW) alterations have been reported as non-traditional biomarker of CVD due to pathophysiological changes, in CKD patients <ref type="bibr" target="#b15">[15,</ref><ref type="bibr" target="#b16">16]</ref>. Abnormalities of the LVW motion are known prognostic marker for MACE prediction in CVD patients. <ref type="bibr" target="#b17">[17]</ref><ref type="bibr" target="#b18">[18]</ref><ref type="bibr" target="#b19">[19]</ref>. Longitudinal dysfunction common in CKD patients, is reflected in LVW with change in morphology <ref type="bibr" target="#b13">[13]</ref>. This dysfunction has been associated with CKD progression <ref type="bibr" target="#b10">[10,</ref><ref type="bibr" target="#b12">12]</ref> and abnormalities are evident even in early stages of CKD <ref type="bibr" target="#b13">[13]</ref>. Thus, an investigation of LVW morphology and longitudinal changes is warranted <ref type="bibr" target="#b10">[10]</ref>.</p><p>Radiomic based interpretable features have been used to model cardiac morphology for predicting disease outcomes <ref type="bibr" target="#b1">[2]</ref>. Deep learning based transformer architectures <ref type="bibr" target="#b20">[20]</ref> have recently been popular for modelling of spatiotemporal changes in LV <ref type="bibr" target="#b8">[9]</ref>. Though they lack interpretability, they are able to extract novel features to model the data using attention <ref type="bibr" target="#b20">[20]</ref>. Thus, in CKD patients, a combination of radiomic and transformer based spatiotemporal models could associate LVW changes over time with progression of CVD and potentially provide some insight into the factors implicated for MACE outcomes.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2">Prior Work and Novel Contributions</head><p>The relationship between Chronic Kidney disease (CKD) and Cardiovascular disease (CVD) is well established <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b21">21]</ref>. Echo provides a noisy yet effective modality for CVD prediction. Echo data (image, video or clinical measurements) has been extensively analyzed using machine learning and deep learning based techniques, to help in diagnosing heart conditions, predicting their severity, and identifying cardiac disease states <ref type="bibr" target="#b1">[2]</ref>. Several studies have employed machine learning to predict diagnostic measurements and global longitudinal strain <ref type="bibr" target="#b22">[22,</ref><ref type="bibr" target="#b23">23]</ref>. In recent years, deep learning-based approaches have been successfully used to tackle echocardiographic segmentation, view classification and phase detection tasks <ref type="bibr" target="#b24">[24,</ref><ref type="bibr" target="#b25">25]</ref>. With advent of EchoNet <ref type="bibr" target="#b6">[7]</ref>, a plethora of studies estimating EF and predicting heart failure have come up <ref type="bibr" target="#b7">[8,</ref><ref type="bibr" target="#b8">9]</ref> while few others have used deep learning for prognostic prediction using cardiac measurements <ref type="bibr" target="#b23">[23]</ref> and to model wall motion abnormalities <ref type="bibr" target="#b18">[18]</ref>.</p><p>Echo coupled with machine learning, has been a potent tool for analysis of CVD in patients with CKD <ref type="bibr" target="#b13">[13]</ref>. Machine learning based analysis has revealed poor prognostic value of EF and LV based biomarkers for CVD risk assessment in CKD patients. <ref type="bibr" target="#b10">[10,</ref><ref type="bibr" target="#b12">12]</ref>. Thus, techniques developed using EchoNet <ref type="bibr" target="#b6">[7]</ref> dataset are potentially less useful for modeling CVD outcomes in CKD patients. The need for a novel approach investigating the longitudinal changes in cardiac structure and function has been recommended for analyzing CVD in patients with CKD <ref type="bibr" target="#b10">[10,</ref><ref type="bibr" target="#b13">13]</ref>.</p><p>In this study, for the first time, we employ echo video based spatiotemporal analysis of LVW to prognosticate CVD outcomes in kidney disease patients. Our code is available here -https://github.com/rohand24/STAR Echo Key contributions of our work are as follows: * STAR-Echo, a novel biomarker that combines spatiotemporal radiomics and transformer-based models to capture morphological differences in shape and texture of LVW and their longitudinal evolution over time. * Unique interpretable features: spatiotemporal evolution of sphericity and perimeter (shape-based) and LongRunHighGrayLevelEmphasis (texturebased), prognostic for CVD risk in CKD patients * Demonstrated the superiority of STAR-Echo in the prognosis of CVD in CKD patients, compared to individual spatiotemporal models and clinical biomarkers. * An end-to-end automated pipeline for echo videos that can identify heartbeat cycles, segment the LVW, and predict a prognostic risk score for CVD in CKD patients.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3">STAR-ECHO: Methodological Description</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1">Notation</head><p>We denote a patient's echo video as a series of two-dimensional frames, represented as V = [I 1 , I 2 , ..., I N ], where I 1 , I 2 , ..., I N represent the N phases (frames) </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3">Systolic Phase Extraction</head><p>The heart-beat cycle is captured using the consecutive end-diastolic phases identified by the CNN+LSTM based multi-beat echo phase detection model <ref type="bibr" target="#b25">[25]</ref>.</p><p>The heart-beat cycle frame lengths vary with individual patients. To achieve a standard frame length of 30 frames, the videos are processed with the following strategy -in videos with extra frames, random frame dropping based on normal distribution is performed, while in videos with fewer frames, a video-frame interpolation model <ref type="bibr" target="#b27">[27]</ref> is utilized to generate frames between randomly selected adjacent frames.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.4">Automated LVW Segmentation</head><p>Since LVW annotations were only available for the end-diastolic phase in the dataset, a weakly supervised segmentation approach is employed to obtain annotations for all phases of the echo video. Combining the available annotations with the publicly available CAMUS dataset <ref type="bibr" target="#b28">[28]</ref>, we trained a nnUNet-based U-Net <ref type="bibr" target="#b29">[29]</ref> model for LVW segmentation. This model was then used to predict LVW for all phases, which were then checked and corrected by two expert annotators.</p><p>Masking the input echo video with LVW mask provides the echo video V , a 30-frame sequence of masked LVW image frames I N , to be input to the spatiotemporal models M R and M T (Fig. <ref type="figure" target="#fig_0">1</ref>). Additionally, each image frame I N is center-cropped and resized to equal k × k dimensions. Thus the input to transformer model M T is an echo video V R 30×k×k .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.5">Spatiotemporal Feature Representation</head><p>Radiomic Time-Series Model: To build this model, we employ a two-stage feature extraction process.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Radiomic Feature Extraction:</head><p>In first stage, radiomic feature R(I N ) is extracted on each I N of the LVW for each phase (frame) of the echo video, V as given in <ref type="bibr" target="#b0">(1)</ref>. Radiomic features comprising of shape <ref type="bibr" target="#b10">(10)</ref>, texture (68) and first-order statistics <ref type="bibr" target="#b19">(19)</ref> of the LVW in each phase of the echo video are extracted using pyradiomics [30] python package on the input echo phase. A total of 97 radiomic features are extracted per echo phase (frame) image I N .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Time Series Feature Extraction:</head><p>In the second stage, to model the temporal LVW motion, we consider the sequence of radiomic features from each phase of one heartbeat cycle as individual time-series. Thus, a radiomic feature timeseries t R (V ) is given by (2). Time-series feature T R , as given by (3), is extracted for each radiomic feature time-series using the TSFresh library <ref type="bibr" target="#b31">[31]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>R(I</head><formula xml:id="formula_0">N ) = f (I N ) (1) t R (V ) = [ R(I 1 ), R(I 2 ), ... , R(I N ) ] (2) T R (V ) = g(t R (V ))<label>(3)</label></formula><p>Thus, the radiomic time-series model M R is trained on time-series features T R (V ) obtained for each V of the patient to predict the outcome O T .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Video Transformer Model:</head><p>The Video Vision Transformer (ViViT) model <ref type="bibr" target="#b26">[26]</ref> with factorised encoder is employed for this task. This architecture has two transformer encoders in series. The first encoder captures the spatial relationships between tokens from the same frame and generates a hidden representation for each frame. The second encoder captures the temporal relationships between frames, resulting in a "late fusion" of temporal and spatial information. The transformer model M T is trained with input echo video V masked with LVW to predict the patient outcome O T . Supplementary table <ref type="table">S3</ref> gives the important hyperparameters used for training the model M T .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.6">Model Fusion</head><p>The predictions from radiomic time-series model, M R and video transformer model, M T are fused at the junction D j linear discriminant analysis (LDA) based fusion, with the output prediction probability P given by ( <ref type="formula" target="#formula_1">4</ref>)</p><formula xml:id="formula_1">log P (y = k|X i ) = ω k X i + ω k0 + C. (<label>4</label></formula><formula xml:id="formula_2">)</formula><p>where ω k , ω k0 are the learned parameters of the model and input X i for patient i is the linear combination of the predictions of M R and M T given as in <ref type="bibr" target="#b4">(5)</ref>,</p><formula xml:id="formula_3">X i = M R (T (R(I N )) i ) + M T (V i )<label>(5)</label></formula></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4">Experimental Results and Discussion</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.1">Dataset Description</head><p>The dataset consisted of echo videos from patients with CKD (N = 150) and their composite CVD outcomes and clinical biomarker measurements for Ejection Fraction (EF), B-type natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP). It was stratified into 70% training (S t = 101) and 30% holdout set (S v = 44) The reported cardiovascular outcome, O T , is composite of following cardiovascular events -chronic heart failure, myocardial infarction and stroke. The patients were participants of the Chronic Renal Insufficiency cohort (CRIC) <ref type="bibr" target="#b21">[21]</ref> and their data was retrospectively made available for this work. The CRIC study <ref type="bibr" target="#b21">[21]</ref> is on individuals with mild to moderate CKD, not on dialysis. Diabetes is the main reported comorbidity for the study.</p><p>The study followed the patients for CVD outcomes. Additional details along with inclusion-exclusion criteria of the dataset are included in the supplementary materials. In the dataset, a total of 46 patients experienced the composite event outcome. The dataset also included survival time information about the patients. The median survival time for patients, O T was 6.5 years (median O - = 6.7 years, median O + = 3.5 years).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.2">Statistical and Survival Analysis</head><p>Statistical Feature Selection -Extracted times-series features (T R ) are normalized and multicollinear features are excluded. Analysis of Variance (ANOVA) based stable feature selection (p &lt; 0.002) and Brouta <ref type="bibr" target="#b32">[32]</ref> based all-relevant feature selection (α = 0.05, threshold = 0.98) is applied sequentially. A Random forest classifier was trained on the training set using 5-fold cross-validation across 100 iterations, and the best model was selected based on AUC. The selected model was applied to the holdout set, and performance metrics were reported.</p><p>Survival Analysis -KM plots with log-rank test analyzed the prognostic ability of models. The curves showed survival time (in years) on the horizontal axis and probability of survival on the vertical axis, with each point representing survival probability of patients. Hazard ratios and p-values were reported for significance between low-risk and high-risk cohorts.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.3">Evaluating Ability of STAR-ECHO to MACE Prognosis</head><p>MACE prognosis is a necessary task in CKD patients management due to high CVD events in CKD patients <ref type="bibr" target="#b33">[33]</ref>. Figure <ref type="figure" target="#fig_1">2</ref> shows the KM curves for each indi- vidual models on the holdout set (S v = 44). Significant separation(p &lt; 0.05) is observed for models M R and STAR-Echo. None of the clinical biomarker models have significant separation. Thus, the models trained on EchoNet <ref type="bibr" target="#b6">[7]</ref>, relying on EF, would not provide a prognostic prediction. Thus, the radiomics features aid in prognosis of MACE risk in CKD patients. The combination model, STAR-Echo, outperforms all the individual models with better risk stratification (p = 0.037 and HR = 2.98) than individual spatiotemporal models(M R : p = 0.042; M T : p = 0.069) and shows high accuracy in prediction compared to M R and M T models. Thus we are able to showcase that saptiotemporal changes in the shape and texture of LVW are prognostic markers for MACE outcomes in CKD patients. Accuracy, area under the ROC curve (AUC), sensitivity, specificity were the prediction metrics and p-value and hazard ratios (HR) were the prognosis metrics observed (Table <ref type="table" target="#tab_0">1</ref>) for all the models, with the model STAR-Echo achieving the highest Accuracy of 70.45% with a significant p-value(= 0.0372) and high HR(= 2.98). No statistically significant difference is observed in AUC performances of the different spatiotemporal models, indicating that the video transformer and the radiomic time-series models are capturing similar spatiotemporal changes in the shape and intensities of the LVW. The individual clinical biomarker based models performed poorly consistent with observations in CKD patients <ref type="bibr" target="#b10">[10,</ref><ref type="bibr" target="#b12">12]</ref>. Thus EchoNet <ref type="bibr" target="#b6">[7]</ref> based models would perform poorly in predicting the MACE outcomes as well.</p><p>The top radiomic features (Fig. <ref type="figure" target="#fig_2">3-A</ref>) include longitudinal changes in perimeter and sphericity of the LVW shape along with intensity changes in the LVW texture. The texture feature changes in systolic function and the shape differences over different frames can be observed in Fig. <ref type="figure" target="#fig_2">3-B</ref>. Changes in the LVW shape can indicate left ventricular hypertrophy (LVH), a common complication of CKD linked to a higher risk of cardiovascular events. LVH can stem from various factors that modify the ventricle's structure and geometry <ref type="bibr" target="#b15">[15]</ref>. Texture changes in LV may also reflect alterations in collagen content or fibrosis which increase the risk of adverse events associated with cardiac remodeling <ref type="bibr" target="#b15">[15]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5">Conclusion</head><p>In this study, we introduced STAR-Echo, a novel biomarker combining radiomics and video transformer-based descriptors to evaluate spatiotemporal changes in LVW morphology. STAR-Echo identifies novel features based on longitudinal changes in LVW shape (perimeter and sphericity) and texture (intensity variations) over a heartbeat cycle, similar to recent clinical pathophysiological findings of CVD in CKD <ref type="bibr" target="#b15">[15]</ref>. Results show that STAR-Echo significantly improves CVD prognosis in CKD patients (AU C = 0.71, p = 0.0372, HR = 2.98) compared to clinical biomarkers, potentially outperforming EchoNet <ref type="bibr" target="#b6">[7]</ref> based LV volumebased approaches. Future research will validate STAR-Echo in a larger patient population and incorporate clinical data for improved management of CVD and CKD.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1 .</head><label>1</label><figDesc>Fig. 1. Workflow of spatiotemporal analysis and STAR-Echo: STAR-Echo does fusion of complementary predictions from spatiotemporal models MR and MT [26]. Input echo videos are preprocessed to identify heart beat cycle between 2 end-diastolic(ED) frames. All echo videos are standardized to 30 frames. The segmented and masked LVW videos are input to the MR and MT pipelines.</figDesc><graphic coords="4,59,97,54,59,332,14,255,10" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 2 .</head><label>2</label><figDesc>Fig. 2. Risk severity analysis using KM curves -Risk stratification using log-rank test shows significant separation only for MR and STAR-Echo (bottom row). ST AR -Echo model demonstrates improved significance (p = 0.037) and high hazard ratio (HR = 2.98[1.01 -8.78]) indicative of prognosis for CVD risk prediction in CKD.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig. 3 .</head><label>3</label><figDesc>Fig. 3. (A) Top features with significant differences (p &lt; 0.05) between MACE outcomes (O -and O + ). (B) The mean feature value difference over time for selected texture feature, between O -and O + . The 3 rd , 13 th , 22 th , 27 th frames are shown for example O -and O + cases. Clear differences in texture and shape are observed between O -and O + , evolving over time.</figDesc><graphic coords="8,65,97,411,80,320,74,121,27" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc>Performance of MR, MT , STAR-Echo, clinical biomarkers in predicting O T .</figDesc><table><row><cell>Model</cell><cell cols="5">Acc. (%) AUC [95% CI] SENS. (%) SPEC. (%) p-value HR</cell></row><row><cell>STAR-Echo</cell><cell>70.45</cell><cell>0.71 [0.53-0.89] 64.29</cell><cell>73.33</cell><cell>0.037</cell><cell>2.98 [1.01-8.78]</cell></row><row><cell>M R</cell><cell>70.45</cell><cell>0.69 [0.50-0.88] 64.29</cell><cell>73.33</cell><cell>0.043</cell><cell>3.40 [1.19-9.71]</cell></row><row><cell>M T</cell><cell>68.18</cell><cell>0.73 [0.58-0.88] 68.18</cell><cell>35.63</cell><cell>0.069</cell><cell>2.56 [0.85-7.72]</cell></row><row><cell>EF( &lt;50)</cell><cell>65.91</cell><cell>0.54 [0.36-0.72] 14.28</cell><cell>90.00</cell><cell>0.59</cell><cell>1.50 [0.26-8.6]</cell></row><row><cell>BNP( &gt;35)</cell><cell>59.90</cell><cell>0.63 [0.44-0.81] 78.57</cell><cell>50.00</cell><cell>0.096</cell><cell>2.82 [0.98-8.11]</cell></row><row><cell cols="2">NT-proBNP( &gt;125) 59.90</cell><cell>0.66 [0.47-0.84] 78.57</cell><cell>50.00</cell><cell>0.089</cell><cell>2.87 [1.0-8.26]</cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div><p>Acknowledgement. Research reported in this publication was supported by the <rs type="funder">National Cancer Institute</rs> under award numbers <rs type="grantNumber">R01CA268287A1</rs>, <rs type="grantNumber">U01 CA269181</rs>, <rs type="grantNumber">R01CA26820701A1</rs>, <rs type="grantNumber">R01CA249992-01A1</rs>, <rs type="grantNumber">R0CA202752-01A1</rs>, <rs type="grantNumber">R01 CA208236-01A1</rs>, <rs type="grantNumber">R01CA216579-01A1</rs>, <rs type="grantNumber">R01CA220581-01A1</rs>, <rs type="grantNumber">R01CA257612-01A1</rs>, <rs type="grantNumber">1U01CA239055-01</rs>, <rs type="grantNumber">1U01CA248226-01</rs>, <rs type="grantNumber">1U54CA254566-01</rs>, <rs type="funder">National Heart, Lung and Blood Institute</rs> <rs type="grantNumber">1R01HL15127701A1</rs>, <rs type="grantNumber">R01HL15807101A1</rs>, <rs type="funder">National Institute of Biomedical Imaging and Bioengineering</rs> <rs type="grantNumber">1R43EB028736-01</rs>, <rs type="projectName">VA Merit Review Award IBX004121A</rs> from the <rs type="funder">United States Department of Veterans Affairs Biomedical Laboratory Research and Development Service the Office</rs> of the Assistant Secretary of Defense for Health Affairs, through the <rs type="programName">Breast Cancer Research Program</rs> (<rs type="grantNumber">W81XWH-19-1-0668</rs>), the <rs type="funder">Prostate Cancer Research Program</rs> (<rs type="grantNumber">W81XWH-20-1-0851</rs>), the <rs type="funder">Lung Cancer Research Program</rs> (<rs type="grantNumber">W81XWH-18-1-0440</rs>, <rs type="grantNumber">W81XWH-20-1-0595</rs>), the <rs type="funder">Peer Reviewed Cancer Research Program</rs> (<rs type="grantNumber">W81XWH-18-1-0404</rs>, <rs type="grantNumber">W81XWH-21-1-0345</rs>, <rs type="grantNumber">W81XWH-21-1-0160</rs>), the <rs type="funder">Kidney Precision Medicine Project (KPMP)</rs> <rs type="grantName">Glue Grant</rs> and sponsored research agreements from <rs type="funder">Bristol Myers-Squibb</rs>, <rs type="funder">Boehringer-Ingelheim</rs>, <rs type="funder">Eli-Lilly</rs> and Astra-zeneca. The content is solely the responsibility of the authors and does not necessarily represent the official views of the <rs type="funder">National Institutes of Health</rs>, the <rs type="funder">U.S. Department of Veterans Affairs</rs>, the <rs type="funder">Department of Defense</rs>, or the <rs type="institution">United States Government</rs>.</p></div>
			</div>
			<listOrg type="funding">
				<org type="funding" xml:id="_hKXzSwD">
					<idno type="grant-number">R01CA268287A1</idno>
				</org>
				<org type="funding" xml:id="_rT779hS">
					<idno type="grant-number">U01 CA269181</idno>
				</org>
				<org type="funding" xml:id="_XUbQsXT">
					<idno type="grant-number">R01CA26820701A1</idno>
				</org>
				<org type="funding" xml:id="_teajDbJ">
					<idno type="grant-number">R01CA249992-01A1</idno>
				</org>
				<org type="funding" xml:id="_xvVjBzX">
					<idno type="grant-number">R0CA202752-01A1</idno>
				</org>
				<org type="funding" xml:id="_HFpDge5">
					<idno type="grant-number">R01 CA208236-01A1</idno>
				</org>
				<org type="funding" xml:id="_VtNcrD4">
					<idno type="grant-number">R01CA216579-01A1</idno>
				</org>
				<org type="funding" xml:id="_nUXYsyt">
					<idno type="grant-number">R01CA220581-01A1</idno>
				</org>
				<org type="funding" xml:id="_r4bEvE2">
					<idno type="grant-number">R01CA257612-01A1</idno>
				</org>
				<org type="funding" xml:id="_yR29XF5">
					<idno type="grant-number">1U01CA239055-01</idno>
				</org>
				<org type="funding" xml:id="_hQ3N8V5">
					<idno type="grant-number">1U01CA248226-01</idno>
				</org>
				<org type="funding" xml:id="_7kUDfDz">
					<idno type="grant-number">1U54CA254566-01</idno>
				</org>
				<org type="funding" xml:id="_Mjuhm24">
					<idno type="grant-number">1R01HL15127701A1</idno>
				</org>
				<org type="funding" xml:id="_PvxXWBN">
					<idno type="grant-number">R01HL15807101A1</idno>
				</org>
				<org type="funded-project" xml:id="_MM5jttU">
					<idno type="grant-number">1R43EB028736-01</idno>
					<orgName type="project" subtype="full">VA Merit Review Award IBX004121A</orgName>
				</org>
				<org type="funding" xml:id="_s3cf8mb">
					<idno type="grant-number">W81XWH-19-1-0668</idno>
					<orgName type="program" subtype="full">Breast Cancer Research Program</orgName>
				</org>
				<org type="funding" xml:id="_tCh3Kmp">
					<idno type="grant-number">W81XWH-20-1-0851</idno>
				</org>
				<org type="funding" xml:id="_abJJRyG">
					<idno type="grant-number">W81XWH-18-1-0440</idno>
				</org>
				<org type="funding" xml:id="_m7yknFd">
					<idno type="grant-number">W81XWH-20-1-0595</idno>
				</org>
				<org type="funding" xml:id="_UvbxgdF">
					<idno type="grant-number">W81XWH-18-1-0404</idno>
				</org>
				<org type="funding" xml:id="_TSAnsDR">
					<idno type="grant-number">W81XWH-21-1-0345</idno>
				</org>
				<org type="funding" xml:id="_e2jDjH4">
					<idno type="grant-number">W81XWH-21-1-0160</idno>
				</org>
				<org type="funding" xml:id="_cGZtrNX">
					<orgName type="grant-name">Glue Grant</orgName>
				</org>
			</listOrg>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Dapagliflozin, advanced chronic kidney disease, and mortality: new insights from the DAPA-CKD trial</title>
		<author>
			<persName><forename type="first">N</forename><surname>Marx</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Floege</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur. Heart J</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">13</biblScope>
			<biblScope unit="page" from="1228" to="1230" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">The role of artificial intelligence in echocardiography</title>
		<author>
			<persName><forename type="first">T</forename><surname>Barry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Farina</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Imaging</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">50</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Fully automated echocardiogram interpretation in clinical practice</title>
		<author>
			<persName><forename type="first">J</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gajjala</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">138</biblScope>
			<biblScope unit="page" from="1623" to="1635" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Automated analysis of doppler echocardiographic videos as a screening tool for valvular heart diseases</title>
		<author>
			<persName><forename type="first">F</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JACC Cardiovasc. Imaging</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="551" to="563" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Differential diagnosis of common etiologies of left ventricular hypertrophy using a hybrid CNN-LSTM model</title>
		<author>
			<persName><forename type="first">I.-C</forename><surname>Hwang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Choi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sci. Rep</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">20998</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">A deep learning framework assisted echocardiography with diagnosis, lesion localization, phenogrouping heterogeneous disease, and anomaly detection</title>
		<author>
			<persName><forename type="first">B</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Chang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sci. Rep</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page">3</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Video-based AI for beat-to-beat assessment of cardiac function</title>
		<author>
			<persName><forename type="first">D</forename><surname>Ouyang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>He</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">580</biblScope>
			<biblScope unit="page" from="252" to="256" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">EchoGNN: explainable ejection fraction estimation with graph neural networks</title>
		<author>
			<persName><forename type="first">M</forename><surname>Mokhtari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Tsang</surname></persName>
		</author>
		<idno type="DOI">10.1007/978-3-031-16440-8_35</idno>
		<ptr target="https://doi.org/10.1007/978-3-031-16440-835" />
	</analytic>
	<monogr>
		<title level="m">MICCAI 2022</title>
		<editor>
			<persName><forename type="first">L</forename><surname>Wang</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Q</forename><surname>Dou</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">P</forename><forename type="middle">T</forename><surname>Fletcher</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">S</forename><surname>Speidel</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">S</forename><surname>Li</surname></persName>
		</editor>
		<meeting><address><addrLine>Cham</addrLine></address></meeting>
		<imprint>
			<publisher>Springer</publisher>
			<date type="published" when="2022">2022</date>
			<biblScope unit="volume">13434</biblScope>
			<biblScope unit="page" from="360" to="369" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">EchoCoTr: estimation of the left ventricular ejection fraction from spatiotemporal echocardiography</title>
		<author>
			<persName><forename type="first">R</forename><surname>Muhtaseb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yaqub</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">MICCAI 2022</title>
		<editor>
			<persName><forename type="first">L</forename><surname>Wang</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Q</forename><surname>Dou</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">P</forename><forename type="middle">T</forename><surname>Fletcher</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">S</forename><surname>Speidel</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">S</forename><surname>Li</surname></persName>
		</editor>
		<imprint>
			<biblScope unit="volume">13434</biblScope>
			<biblScope unit="page" from="370" to="379" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Cham</forename><surname>Springer</surname></persName>
		</author>
		<idno type="DOI">10.1007/978-3-031-16440-8_36</idno>
		<ptr target="https://doi.org/10.1007/978-3-031-16440-836" />
		<imprint>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Prognostic value of echocardiography for heart failure and death in adults with chronic kidney disease</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Fitzpatrick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Ambrosy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. Heart J</title>
		<imprint>
			<biblScope unit="volume">248</biblScope>
			<biblScope unit="page" from="84" to="96" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Left ventricular dysfunction with preserved ejection fraction: the most common left ventricular disorder in chronic kidney disease patients</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">B</forename><surname>Mark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Mangion</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin. Kidney J</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="2186" to="2199" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Prediction of incident heart failure in CKD: the CRIC study</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">R</forename><surname>Zelnick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Shlipak</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney Int. Rep</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="708" to="719" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Echocardiographic assessment of cardiac structure and function in chronic renal disease</title>
		<author>
			<persName><forename type="first">K</forename><surname>Dohi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Echocardiogr</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="115" to="122" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Left ventricular structure and function in patients with chronic kidney disease assessed by 3D echocardiography: the CPH-CKD ECHO study</title>
		<author>
			<persName><forename type="first">J</forename><surname>Christensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">E</forename><surname>Landler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int. J. Cardiovasc. Imaging</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="1233" to="1244" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Cardiovascular disease in chronic kidney disease</title>
		<author>
			<persName><forename type="first">J</forename><surname>Jankowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Floege</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">143</biblScope>
			<biblScope unit="page" from="1157" to="1172" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Target organ cross talk in cardiorenal syndrome: animal models</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Bongartz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Braam</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Physiol. Renal Physiol</title>
		<imprint>
			<biblScope unit="volume">303</biblScope>
			<biblScope unit="page" from="1253" to="F1263" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Association of major adverse cardiovascular events in patients with stroke and cardiac wall motion abnormalities</title>
		<author>
			<persName><forename type="first">S</forename><surname>Kamran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Akhtar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Am. Heart Assoc</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">20888</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Automated recognition of regional wall motion abnormalities through deep neural network interpretation of transthoracic echocardiography</title>
		<author>
			<persName><forename type="first">M.-S</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C.-S</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">142</biblScope>
			<biblScope unit="page" from="1510" to="1520" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Prognostic significance of the location of wall motion abnormalities during exercise echocardiography</title>
		<author>
			<persName><forename type="first">A</forename><surname>Elhendy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Mahoney</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Am. Coll. Cardiol</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="1623" to="1629" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Attention is all you need</title>
		<author>
			<persName><forename type="first">A</forename><surname>Vaswani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Shazeer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Advances in Neural Information Processing Systems</title>
		<imprint>
			<publisher>Curran Associates Inc</publisher>
			<date type="published" when="2017">2017</date>
			<biblScope unit="volume">30</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Chronic renal insufficiency cohort study</title>
		<author>
			<persName><forename type="first">H</forename><surname>Feldman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Dember</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Artwork Size: 263268080 MB Pages: 263268080 MB Version Number: V11 Type: dataset</title>
		<imprint>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Artificial intelligence for automatic measurement of left ventricular strain in echocardiography</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Salte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Østvik</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JACC Cardiovasc. Imaging</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<date type="published" when="1918">1918-1928 (2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Deep-learning models for the echocardiographic assessment of diastolic dysfunction</title>
		<author>
			<persName><forename type="first">A</forename><surname>Pandey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kagiyama</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JACC Cardiovasc. Imaging</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="1887" to="1900" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Real-time echocardiography image analysis and quantification of cardiac indices</title>
		<author>
			<persName><forename type="first">G</forename><surname>Zamzmi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rajaraman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Med. Image Anal</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="page">102438</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Multibeat echocardiographic phase detection using deep neural networks</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Lane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Azarmehr</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Comput. Biol. Med</title>
		<imprint>
			<biblScope unit="volume">133</biblScope>
			<biblScope unit="page">104373</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">ViViT: a video vision transformer</title>
		<author>
			<persName><forename type="first">A</forename><surname>Arnab</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dehghani</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">2021 IEEE/CVF International Conference on Computer Vision (ICCV)</title>
		<meeting><address><addrLine>Montreal, QC, Canada</addrLine></address></meeting>
		<imprint>
			<publisher>IEEE</publisher>
			<date type="published" when="2021">2021</date>
			<biblScope unit="page" from="6816" to="6826" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Multiple video frame interpolation via enhanced deformable separable convolution</title>
		<author>
			<persName><forename type="first">X</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">IEEE Trans. Pattern Anal. Mach. Intell</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="7029" to="7045" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Deep learning for segmentation using an open largescale dataset in 2D echocardiography</title>
		<author>
			<persName><forename type="first">S</forename><surname>Leclerc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Smistad</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">IEEE Trans. Med. Imaging</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="2198" to="2210" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">nnU-Net: a self-configuring method for deep learning-based biomedical image segmentation</title>
		<author>
			<persName><forename type="first">F</forename><surname>Isensee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">F</forename><surname>Jaeger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Methods</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page">30</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Computational radiomics system to decode the radiographic phenotype</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Van Griethuysen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fedorov</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Can. Res</title>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="page" from="104" to="e107" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Time series feature extraction on basis of scalable hypothesis tests (tsfresh -a python package)</title>
		<author>
			<persName><forename type="first">M</forename><surname>Christ</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Braun</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurocomputing</title>
		<imprint>
			<biblScope unit="volume">307</biblScope>
			<biblScope unit="page" from="72" to="77" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Feature selection with the Boruta package</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Kursa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Rudnicki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Stat. Softw</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="1" to="13" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Screening for cardiovascular disease in CKD: PRO</title>
		<author>
			<persName><forename type="first">N</forename><surname>Jain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mcadams</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney</title>
		<imprint>
			<biblScope unit="volume">360</biblScope>
			<biblScope unit="page">1831</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
